Clinic for LAM & Rare Diseases
The Clinic for LAM / Rare Lung Diseases of UT Physicians
Our Clinic for Lymphangioleiomyomatosis (LAM) and Rare Lung Diseases participates in local and national research initiatives to learn more about LAM. Patients have the opportunity to participate in these research studies to further knowledge of lymphangioleiomyomatosis (LAM), and many communicate through support groups and online via social media.
We see patients with diffuse pulmonary cystic diseases as well as rare lung diseases based on referrals.
What is Lymphangioleiomyomatosis (LAM)?
Lymphangioleiomyomatosis, also known simply as “LAM,” is a rare cystic lung disease that affects women of predominantly child-bearing age. The LAM Foundation has designated McGovern Medical School at UTHealth, as one of almost 30 specialty clinics in the United States and the only one in the Houston area dedicated exclusively for the care of lymphangioleiomyomatosis (LAM) patients.
Figure A shows the location of the lungs and airways in the body. The inset image shows a cross-section of a healthy lung. Figure B shows a view of the lungs with lymphangioleiomyomatosis (LAM) and a collapsed lung (pneumothorax). The inset image shows a cross-section of a lung with lymphangioleiomyomatosis (LAM). Source: National Heart Lung & Blood Institute, copyright in public domain.
Mission of Clinic of Lymphangioleiomyomatosis (LAM) & Rare Lung Diseases
We break down our mission statement into four key focus areas: clinical care, community, education, and research.
Clinical Care: To provide a compassionate, comprehensive, state of the art, and evidence-based approach to the diagnosis and treatment of patients with lymphangioleiomyomatosis (LAM) & rare lung diseases
Community: To disseminate awareness and educate the public about the spectrum of lymphangioleiomyomatosis (LAM) & rare lung diseases
Education: To train future specialist physicians in the diagnosis and empathetic treatment of patient living with lymphangioleiomyomatosis (LAM) & rare lung diseases
Research: To advance the science and contribute to the knowledge in lymphangioleiomyomatosis (LAM) & rare lung diseases) through cooperative and multidisciplinary involvement in discovering novel ideas on the causes, mechanisms of disease development, and disease progression, all while exploring new avenues of treatment
Meet Our Physician
Dr. Rosa Estrada-Y-Martin is the academic pulmonologist and Medical Director of the LAM Clinic leading LAM-related patient care and research. She is Professor of Medicine in the Department of Internal Medicine in our Divisions of Pulmonary & Sleep Medicine and Critical Care Medicine.
Patients are referred to this clinic from both within and outside of Texas, and Dr. Estrada-Y-Martin works closely with patients’ primary care and pulmonary specialist physicians to ensure patients with lymphangioleiomyomatosis (LAM) and/or rare lung diseases receive the most up-to-date evidence-based care.
Clinic Location, Day and Times
UT Professional Building
6410 Fannin Street, Suite 600
Houston, TX 77030
Dr. Rosa Estrada-Y-Martin – 2nd Monday of each month from 1:00 pm to 5:00 pm
Ph: 832-325-7222; Fax: 713-512-2247
Patient Resources
- Learn about Lymphangioleiomyomatosis (LAM) from the the LAM Foundation: https://www.thelamfoundation.org/
- LAM Foundation on Facebook: https://www.facebook.com/TheLAMFoundation/